Scarica l'app Stockscreener
560.11
2.11%
-12.09
Pre-mercato:
559.44
-0.67
-0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$572.20
Aprire:
$572.2
Volume 24 ore:
476.45K
Relative Volume:
0.89
Capitalizzazione di mercato:
$44.18B
Reddito:
$4.45B
Utile/perdita netta:
$1.10B
Rapporto P/E:
41.21
EPS:
13.591
Flusso di cassa netto:
$1.06B
1 W Prestazione:
-1.30%
1M Prestazione:
-5.36%
6M Prestazione:
-20.94%
1 anno Prestazione:
+14.31%
Intervallo 1D:
$555.18
$572.20
Intervallo di 1 settimana:
$550.00
$585.12
Portata 52W:
$487.30
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, WAT, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
560.11 | 44.18B | 4.45B | 1.10B | 1.06B | 13.59 |
TMO
Thermo Fisher Scientific Inc
|
465.00 | 172.80B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
171.16 | 121.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
WAT
Waters Corp
|
355.13 | 34.86B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.62 | 32.67B | 7.07B | 1.29B | 993.00M | 4.5355 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Neutral |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
What you need to know ahead of IDEXX Laboratories' earnings release - MSN
IDEXX Laboratories stock (US45168D1046): Mixed price moves amid strong earnings and valuation debate - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here’s Why IDEXX Laboratories Stock Could Deliver Around 11% Annual Returns Despite a 15% YTD Pullback - TIKR.com
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analyst Estimates: Here's What Brokers Think Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Its First-Quarter Report - Yahoo Finance
Companion Animal Diagnostics Market Valued at USD 7.6 Billion - openPR.com
Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $729 - Moomoo
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805 - Moomoo
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675 - Moomoo
IDEXX Laboratories Q1 2026 earnings preview - MSN
Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call - Sahm
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2026 Earnings Call Transcript - Insider Monkey
Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785 - marketscreener.com
IDEXX Laboratories Lifts Guidance on Robust Q1 - TipRanks
BofA cuts Idexx Laboratories stock price target on macro concerns By Investing.com - Investing.com South Africa
IDEXX (NASDAQ: IDXX) lifts Q1 profit and ramps up buybacks - Stock Titan
BofA cuts Idexx Laboratories stock price target on macro concerns - Investing.com
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $660 - 富途牛牛
Idexx Earnings: Strong Quarterly Results Lead to a More Optimistic Outlook From Management - Morningstar
IDEXX Laboratories Q1 Earnings Call Highlights - Yahoo Finance
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - 富途牛牛
IDEXX Laboratories, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IDXX) 2026-05-05 - Seeking Alpha
IDEXX Laboratories, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
IDEXX Q1 2026 slides: raised guidance on strong diagnostic growth - Investing.com
Earnings call transcript: IDEXX Labs exceeds Q1 2026 forecasts, stock rises - Investing.com Nigeria
IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View Up - Yahoo Finance
Earnings call transcript: IDEXX Labs exceeds Q1 2026 forecasts, stock rises By Investing.com - Investing.com South Africa
Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency - Benzinga
IDEXX beats expectations on Q1 results, raises 2026 outlook - Mainebiz
Is It Too Late To Consider IDEXX Laboratories (IDXX) After Its 18.5% One-Year Rally? - Yahoo Finance
IDEXX Laboratories Releases Q1 2026 Financial Results - AlphaStreet
IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise - marketscreener.com
Q1 2026 IDEXX Laboratories Inc Earnings Call Transcript - GuruFocus
Research Alert: Idexx Posts Solid Q1 Fueled By Innovation And Strong Cag Group Performance - Moomoo
IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MSN Money - MSN
Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
IDEXX Laboratories (NASDAQ:IDXX) Beats and Raises on Strong Demand, Sending Shares Up - ChartMill
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 Comparable EPS $3.30, vs. FactSet Est of $3.39 - marketscreener.com
IDEXX LABS ($IDXX) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q1 Revenue $1.14B, vs. FactSet Est of $1.12B - marketscreener.com
IDEXX Laboratories : Earnings snapshot Q1 2026 - marketscreener.com
Idexx: Q1 Earnings Snapshot - KVUE
IDEXX posts Q1 revenue $1.141B, EPS $3.47; raises 2026 revenue and EPS outlook - TradingView
IDEXX Laboratories Inc | 8-K: IDEXX Laboratories Announces First Quarter Results - Moomoo
Press Release: IDEXX Laboratories Announces First Quarter Results - Moomoo
Long-Term Leaders: Boston Scientific Joins Watchlist, Motorola Out - Investor's Business Daily
Idexx Laboratories (IDXX) Margin Strength Reinforces Bullish Earnings Narrative Before Q1 2026 - Sahm
IDEXX (NASDAQ: IDXX) director defers $24,375 into stock units - Stock Titan
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):